Australia markets open in 36 minutes

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4800-0.0300 (-1.99%)
At close: 04:00PM EDT
1.4900 +0.01 (+0.68%)
After hours: 07:21PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-141,405
-141,405
-19,816
-98,776
-67,475
Depreciation & amortisation
551
551
418
355
334
Stock-based compensation
15,563
15,563
14,890
13,867
7,642
Change in working capital
2,169
2,169
-6,092
28,699
-2,042
Accounts payable
-
-
-
7,841
1,877
Other working capital
-118,120
-118,120
-114,660
-58,366
-60,912
Other non-cash items
5,060
5,060
3,331
1,065
626
Net cash provided by operating activities
-118,001
-118,001
-112,886
-55,477
-60,912
Cash flows from investing activities
Investments in property, plant and equipment
-119
-119
-1,774
-2,889
-
Purchases of investments
-51,995
-51,995
0
0
-8,931
Sales/maturities of investments
23,500
23,500
107,375
1,474
8,193
Net cash used for investing activities
-28,605
-28,605
105,772
-1,415
-738
Cash flows from financing activities
Debt repayment
0
-
-42
0
-
Common stock issued
25,823
25,823
64,477
0
108,196
Other financing activities
-
-
-42
-148
-
Net cash used provided by (used for) financing activities
26,627
26,627
124,738
41,310
109,216
Net change in cash
-119,979
-119,979
117,624
-15,582
47,566
Cash at beginning of period
240,551
240,551
122,927
138,509
90,943
Cash at end of period
120,572
120,572
240,551
122,927
138,509
Free cash flow
Operating cash flow
-118,001
-118,001
-112,886
-55,477
-60,912
Capital expenditure
-119
-119
-1,774
-2,889
-
Free cash flow
-118,120
-118,120
-114,660
-58,366
-60,912